Thus, these results suggest that the presence of MDSCs (expressing a CD11b+/Gr-1+ phenotype) in the tumor tissues might be responsible for inhibiting Ag-specific CTL induction and/or blocking antitumor CTL effector functions, allowing for continuous tumor growth in the CT26/HER2 tumor model. This evidence concerns the gene DDX53 and neoplasm.